Publications by authors named "Eric Claassen"

Claim this Profile
T
The pharmaceutical productivity gap - Incremental decline in R&D efficiency despite transient improvements.
Kenneth D S Fernald, Philipp C Förster, Eric Claassen, Linda H M van de Burgwal

Drug Discov Today· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Innovative AI-based primer design tool for precise and accurate detection of SARS-CoV-2 variants of concern.
Carmina Angelica Perez-Romero, Lucero Mendoza-Maldonado, Alberto Tonda, Etienne Coz, Patrick Tabeling, Eric Claassen

Sci Rep· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A survival of the fittest strategy for the selection of genotypes by which drug responders and non-responders can be predicted in small groups.
Daniël Höhle, Kim van Rooij, Jos Bloemers, James G Pfaus, Frits Michiels, Eric Claassen

PLoS One· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Barriers Influencing Vaccine Development Timelines, Identification, Causal Analysis, and Prioritization of Key Barriers by KOLs in General and Covid-19 Vaccine R&D.
Marga Janse, Thomas Brouwers, Eric Claassen, Peter Hermans, Linda van de Burgwal

Front Public Health· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probiotics as a treatment for prenatal maternal anxiety and depression: a double-blind randomized pilot trial.
Pamela D Browne, Antoinette C Bolte, Isolde Besseling-van der Vaart, Eric Claassen, Carolina de Weerth

Sci Rep· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Classification and specific primer design for accurate detection of SARS-CoV-2 using deep learning.
Alejandro Lopez-Rincon, Alberto Tonda, Lucero Mendoza-Maldonado, Daphne G J C Mulders, Richard Molenkamp, Eric Claassen

Sci Rep· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lower Respiratory Tract Infection Trends in East and South-East Asia: In the Light of Economic and Health Care Development.
Jelle J Feddema, Anne M van der Geest, Eric Claassen, Linda H M van de Burgwal

Glob Pediatr Health· January 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Blockchain-facilitated sharing to advance outbreak R&D.
Mark B van der Waal, Carolina Dos S Ribeiro, Moses Ma, George B Haringhuizen, Eric Claassen

Science· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantity vs. quality: an assessment of the current pipeline for rabies.
Anne M G Neevel, Eduardo Urias, Eric Claassen, Linda H M van de Burgwal

Trop Med Int Health· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Probiotics in pregnancy: protocol of a double-blind randomized controlled pilot trial for pregnant women with depression and anxiety (PIP pilot trial).
Pamela D Browne, Antoinette Bolte, Eric Claassen, Carolina de Weerth

Trials· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The underexposed role of food matrices in probiotic products: Reviewing the relationship between carrier matrices and product parameters.
Joost Flach, Mark B van der Waal, Maurits van den Nieuwboer, Eric Claassen, Olaf F A Larsen

Crit Rev Food Sci Nutr· May 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functions of CD40 and Its Ligand, gp39 (CD40L).
Jon D Laman, Eric Claassen, Randolph J Noelle

Crit Rev Immunol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a rational design of faecal transplant analogues.
Olaf F A Larsen, Anton H J Koning, Peter J van der Spek, Eric Claassen

Sci Rep· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
How ownership rights over microorganisms affect infectious disease control and innovation: A root-cause analysis of barriers to data sharing as experienced by key stakeholders.
Carolina Dos S Ribeiro, Martine Y van Roode, George B Haringhuizen, Marion P Koopmans, Eric Claassen

PLoS One· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A research agenda to reinforce rabies control: A qualitative and quantitative prioritization.
Anne M G Neevel, Tessa Hemrika, Eric Claassen, Linda H M van de Burgwal

PLoS Negl Trop Dis· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The mechanistic link between health and gut microbiota diversity.
Olaf F A Larsen, Eric Claassen

Sci Rep· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vector-based genetically modified vaccines: Exploiting Jenner's legacy.
Bahar Ramezanpour, Ingrid Haan, Ab Osterhaus, Eric Claassen

Vaccine· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venturing across the Atlantic.
Rogier W Rooswinkel, Daan S W Berbers, Eric H J H M Claassen, Sander van Deventer

Nat Biotechnol· November 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Self-Centric and Altruistic Unmet Needs for Ebola: Barriers to International Preparedness.
Linda H M Van de Burgwal, Leslie A Reperant, Albert D M E Osterhaus, Sorana C Iancu, Esther S Pronker, Eric Claassen

Disaster Med Public Health Prep· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lactobacillus plantarum WCFS1 and its host interaction: a dozen years after the genome.
Maurits van den Nieuwboer, Saskia van Hemert, Eric Claassen, Willem M de Vos

Microb Biotechnol· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trade-sale exits in different biotech sectors.
Kenneth Fernald, Eric Claassen

Nat Biotechnol· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-effectiveness in Clostridium difficile treatment decision-making.
Mark Jc Nuijten, Josbert J Keller, Caroline E Visser, Ken Redekop, Eric Claassen

World J Clin Cases· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Food-pharma convergence in medical nutrition- best of both worlds?
Tamar C Weenen, Bahar Ramezanpour, Esther S Pronker, Harry Commandeur, Eric Claassen

PLoS One· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-benefit relation of diet and probiotics in iatrogenic bowel irregularity (IBI).
Eric Claassen

Front Pharmacol· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk in vaccine research and development quantified.
Esther S Pronker, Tamar C Weenen, Harry Commandeur, Eric H J H M Claassen, Albertus D M E Osterhaus

PLoS One· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis